Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
Journal of Clinical Medicine|December 17, 2024
Whole Gut Motility Patterns in Patients with Chronic Nausea and VomitingMette W Klinge, Anne Mette Haase, Nanna Sutter Rolighed, et al.Cancers|June 2, 2021
High Monocyte Count and Expression of <i>S100A9</i> and <i>S100A12</i> in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate CancerAnna-Maja Åberg, Sofia Halin Bergström, Elin Thysell, et al.Cancer Research|May 1, 2014
Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15Francesca Bruzzese, Christina Hägglöf, Alessandra Leone, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 12, 2010
Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activationPhilip P Fitchev, Susan M Wcislak, Chung Lee, et al.Human Pathology|October 3, 2012
Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomyTuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, et al.Molecular Oncology|June 5, 2019
Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumorElin Thysell, Linda Vidman, Erik Bovinder Ylitalo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2018
The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic ImplicationsDiego Iglesias-Gato, Elin Thysell, Stefka Tyanova, et al.The New England Journal of Medicine|September 25, 2024
Results after Four Years of Screening for Prostate Cancer with PSA and MRIJonas Hugosson, Rebecka Arnsrud Godtman, Jonas Wallstrom, et al.Communications Medicine|November 9, 2023
The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomographyErik Nilsson, Kristina Sandgren, Josefine Grefve, et al.Molecular Oncology|June 10, 2025
Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease modelsJohanna Classon, Moa Stenudd, Margherita Zamboni, et al.Pageof 19